United Kingdom · Ageing Society, Health & Nutrition
Kindling Bio Ltd
Kindling Bio Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Sep 2026.
Announcements
Innovate UK funding awarded
£99,995 · Innovation Loans; “In Vivo Proof-of-Concept for a Tumour-Agnostic Immune Flag Platform in Paediatric Solid Tu”; North West
Innovate UK funding awarded
£59,951 · Collaborative R&D grant; “Development of a Novel Immunotherapy Platform for High-Risk Childhood Cancers”; London
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.